$2.93
Today
as of Jul 22, 16:49 ET
Last 30 days
Recent Press Releases & News
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
GoodRx (GDRX) Stock Trades Up, Here Is Why
Overview
52-week range
$1.77
$5.81
29% of range
Avg surprise (last 3)
+8.3%
Avg reaction (last 2)
-5.3%
50% positive
Latest IV / EM
209%
EM ±47.8% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.03 | $0.03 | 0.0% | -40.0% | +0.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | — | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.05 | $0.05 | 0.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.05 | $0.04 | +25.0% | — | -11.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.02 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | — | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.09 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.14 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | AMC | $0.04 | $0.05 | -20.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $194M | — | $196M | $203M | $203M | — | $195M | $201M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $14M | — | $15M | $27M | $23M | — | $20M | $20M |
| Net income | $1M | — | $1M | $13M | $11M | — | $4M | $7M |
| EPS (diluted) | — | — | — | $0.04 | $0.03 | — | $0.01 | $0.02 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $236M | $262M | $274M | $281M | $301M | $448M | $424M | $525M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.27B | $643M | $566M | $551M | $540M | $659M | $627M | $751M |
| Total assets | $2.02B | $1.40B | $1.33B | $1.32B | $1.30B | $1.39B | $1.35B | $1.48B |
| Long-term debt | $482M | $483M | $484M | $485M | $486M | $487M | $488M | $646M |
| Total liabilities | $1.40B | $788M | $725M | $676M | $641M | $663M | $658M | $806M |
| Total equity | $622M | $616M | $601M | $643M | $654M | $725M | $696M | $669M |